Trinity Vet Centre has launched an Android version of its iPhone / iPad app: Veterinary Care of Exotic Pets.
Designed for veterinary surgeons, veterinary students and veterinary nurses, the app gives the viewer an interactive experience in the care of exotic animals and includes videos of blood sampling, images of sex determination and images of common conditions including avian radiographic interpretation.
The app also contains formularies for all the commonly encountered exotic species, lists of commonly seen conditions (and their treatment) and biological data all at the touch of the screen. In addition the latest update for the iPhone / iPad features new sections on birds of prey and poultry which will also be available on the android version.
The app's developer, zoological medicine certificate holder Mark Rowland said: "This app is here to help vets offer the same high level of service offered to dog and cat clients to exotic animals which are becoming even more common. Data such as gestation periods and drug doses for exotics can easily be accessed. The videos are there to show in more detail how to blood sample exotics from Guinea Pigs to Tortoises"
The app is available from your iPhone or Android App store, priced at £7.99
The campaign was officially launched at an event at the Palace of Westminster sponsored by Kevan Jones MP (Labour, North Durham) who has spoken about his own experiences with depression, and featured first-hand testimonials from senior veterinary surgeons and doctors who have experienced mental ill-health.
‘&me’ is a collaboration between the RCVS Mind Matters Initiative, which seeks to address mental health and wellbeing issues within the veterinary profession, and the Doctors’ Support Network, which provides peer support for doctors and medical students with mental health concerns.
Introducing the campaign, Mr Jones said: "The key message I have today in regards to mental health is talking about it and trying to get it out of the dark corners rather than it being something you are ashamed to talk about. That is how we get people to help themselves with their own condition and to seek help. The other key thing is not to write people off if they have a mental illness."
The floor was then opened to personal stories from those who have lived experience of mental ill-health. Dr Louise Freeman is Vice-Chair of the Doctors’ Support Network and was diagnosed with depression in 2009 as a result of the way in which her return to work was handled after having time off work as an emergency medicine consultant following a bereavement.
She said: "This experience made me think that doctors with mental health problems were in a small minority and that it was probably our own fault anyway. Both impressions are completely wrong. The incidence of mental health problems is one in four people in any one year and is actually higher for doctors, who are often slower to seek help than non-medics. The good news is that well supported doctors have excellent treatment outcomes.
"During my own return to work, I was told by my clinical lead that they had 'always thought that I was a mental health problem waiting to happen.' I think this says more about them than it did about me! On reflection, yes that was true, but only inasmuch as this applies to all of us during our lives.
"I hope that the ‘&me’ campaign can start to address this by encouraging senior healthcare professionals, who are currently well, but have experienced mental health problems, to disclose that they have 'been there themselves'. I think that this will help to normalise mental ill health for healthcare professionals and therefore remove some of the barriers to unwell professionals seeking help at an earlier stage. Overall this would be better for healthcare professionals, their colleagues and their patients."
David Bartram, Director of Outcomes Research for the international operations of the largest global animal health company and a member of the Royal College of Veterinary Surgeons' governing Council, spoke next. He gave his perspective on coming to terms with a mental health condition in a profession that has some stigma attached to it.
A number of years ago David attempted suicide following the breakup of his marriage and explains what happened from there: "I just thought I was stressed – after all, who wouldn’t be in those circumstances? But in fact I was becoming progressively more unwell. What started as worry, early waking and palpitations – which I recognised – led to patterns of thinking which I did not recognise as being disordered. I felt trapped and worthless – suicide was the only escape. From a medical perspective, my biological, social and psychological risk factors had converged and tipped me into major depression.
"That was the first of multiple suicide attempts and several prolonged stays in hospital. Over a three-year period I spent 12 months as a psychiatric inpatient. I was treated with antidepressants, antipsychotics, mood stabilisers, talking therapies and electroconvulsive therapy.
"But now thankfully I am well – and I have been for 14 years…. To what do I attribute my recovery? A mixture of medical treatment, psychological therapies, supportive friends and family, rest and time – they all contributed, probably in similar measure."
He added that while his episode of mental ill-health does not define him it has changed him in a positive way and that no one is immune from it.
Dr Jonathan Richardson is Group Medical Director for Community Services at the Northumberland, Tyne and Wear NHS Foundation Trust who had a mental health condition when he was a medical student and spoke about how it is possible to flourish in your career with a mental health diagnosis.
"I was unwell as a teenager with a physical illness and later as a medical student with a mental illness… these two experiences crystallised my drive to become a doctor and my own approach to healthcare. I wanted to be able to deliver the care that I was fortunate to receive. I wanted to be as patient-centred and compassionate with the patients I would serve, in the same way as the teams who delivered my care. I was lucky to have support when I was unwell from very good friends, some from school and some from university; and a very close family. I have been able to recover.
"It is 24 years since my mental illness. I now work in Northumberland, Tyne and Wear NHS Foundation Trust, one of the largest mental and learning disability health trusts in England – and one of only two to be rated outstanding by the Care Quality Commission…. I do not feel that my illnesses have stopped me."
Dr Angelika Luehrs is the chair of the Doctors’ Support Network and a consultant psychiatrist who was diagnosed with bipolar affective disorder while she was a trainee psychiatrist. She said: “When I asked for advice about how to access help one of the answer I got was one of ‘whatever you do, make sure that you don't have any mental illness in your medical records otherwise you will never go anywhere in your medical career. However, getting the diagnosis and help from a Consultant Psychiatrist was the best thing that ever happened.”
She added: "The reality is that my diagnosis has not stopped me – I have been a consultant psychiatrist since 2010 with the Avon and Wiltshire Mental Health Partnership NHS Trust, last year I was appointed as medical lead for West Wiltshire including early intervention, intensive services and primary care liaison services. I have a special interest in supporting doctors with mental illness and I am delighted to be appointed by the newly launched GP Health Service as a special advisor for complex mental health cases."
The last speaker was veterinary surgeon Neil Smith who chairs the RCVS Mind Matters Initiative and outlined how to participate in the campaign. He said: "This event is just the start… the real challenge is to start to get this message out to the wider professions. Stigma is a difficult thing to tackle, but the good news is that changing our minds is within the power of every individual to do."
Following the launch the ‘&me’ campaign is now encouraging other senior health professionals to step forward and talk about their own experiences with mental ill-health, especially as both medical doctors and veterinary surgeons have higher suicide rates than the general population but often have more reluctance to seek help because of the impact it may have on their career.
The campaign is interested in hearing from not only doctors and veterinary surgeons but also nurses, veterinary nurses, dentists, pharmacists and other healthcare professionals who want to open up about their experiences of mental ill-health. To participate in the campaign email Dr Louise Freeman on vicechair@dsn.org.uk.
Further information about the ‘&me’ campaign can be found at www.vetmindmatters.org/&me
ATOP 7 Mousse and PYOclean Mousse are presented as a ‘dry shampoo’ in foam form for cats and dogs. They join the company's Dermoscent portfolio of companion animal products, developed to help with the management of scaling disorders, atopic or allergic skin disease and infections.
Both products contain a blend of plant extracts and essential oils from Hemp seed, which LDCA says has a moisturising and restructuring action on the skin. Atop 7 contains lemon tea tree extract, which the company says boosts anti-inflammatory and anti-pruritic activity. PYOclean contains lavender and manuka, which are claimed to have an anti-bacterial action.
LDCA says it has designed the two non-rinse mousses with owner compliance in mind; that used twice-weekly twice-weekly alone or in combination with other supplements or treatments as part of a skincare protocol, they can extend the time between shampoos. They can also be applied quickly to speed patients’ discharge from hospital or used when animals are boisterous or dislike baths.
According to the company, a 2-week veterinary-supervised study looking at the effect of ATOP 7 Mousse on the skin of flea-allergic and atopic dogs, reported a veterinarian general satisfaction score of 8.7/10. Owners of the dogs on the trial reported an 8.7/10 general satisfaction score and a similar score for the product’s ability to soothe irritated skin.¹
The full Dermoscent range, including the new mousses, is available through Vet Direct as well as Henry Schein (selected products) or as a special order through Centaur. ATOP 7 Mousse and PYOclean Mousse are both available in 150ml packs and are priced at £7.94 + VAT each (list price).
For more information visit: http://www.dermoscent.com. A clinical case study by Dr Jean-Loup Mathet on the use of PYOclean Shampoo, Spray and Mousse in a 14-year old West Highland White Terrier with chronic, recurrent, inflammatory, pruritic and seborrhoeic dermatosis is also available online or by request.
Reference
The theme for the 2025 conference is how to make veterinary work sustainable, creating teams that can reliably work at their best, feel positive about work, and feel supported and valued by their team.
Keynote speaker, Amanda Oates BA (hons), MSc Strategic HRD, C.C.I.P.D. (pictured) will be talking about the concept of restorative veterinary practice, and how it relies on establishing a restorative workplace culture.
There will be three streams at the conference.
In the first stream, VetLed founder and Training Director, Dan Tipney will be joined by guest speakers to help delegates understand how they can make a difference to the way they work using human factors tools and techniques proven in human medicine and other safety-critical professions.
In the second stream, VetLed’s Community Lead, Hannah Godfrey, will be joined by human behaviour expert Katie Ford to help delegates understand themselves as humans, to acknowledge and accommodate their own needs and the needs of others, and to work better as a team.
The third stream will be hosted by VetLed Managing Director, Cat Auden, and a Chartered Psychologist, Ergonomist, and Human Factors Specialist. In this stream, delegates who are already familiar with human factors concepts will be encouraged to think big, share ideas, and shape the veterinary profession.
Tickets: £190.80
https://www.vetled.co.uk/conference
Epiphen, Vétoquinol's canine anti-epileptic drug, has been re-launched with new packaging and a useful dosing syringe.
"Some of our customers reported that they were having difficulty administering the drops accurately," explains Slavica Sobot, Product Manager. "So with this in mind, we have introduced a new plug-on syringe which will make it even easier for pet owners to dose accurately. The syringe will prevent the risk of inaccurate dosing through ‘flooding' from the dropper."
For more information, please call the Vétoquinol help line on 0800 169 8197 or contact your Vétoquinol representative.
The full BEVA Congress programme is now live and super early bird tickets are available from 4th March, saving member delegates up to £200.
The one medicine thread will run through the medicine and orthopaedics and sports medicine streams as well as feature in the Peter Rossdale Plenary Lecture.
BEVA President Roger Smith said “There is much to learn from the human side as well as from what we do as vets.
"We have invited five human medical experts to make some comparative links with human medicine in their presentations.
"Bringing a different angle in this way will help predict what the future holds and advance what we do in the equine veterinary sphere.”
The full programme includes more than 90 hours of live and on-demand CPD covering almost every aspect of equine medicine, surgery and practice.
The first day will commence with an opening address from Olympic gold medallist Sally Gunnell during which she will share her thoughts on maximising performance.
Other highlights include:
Individual super early bird BEVA members prices are £524 for vets and £144 for vet nurses for all three days (with concessionary available for those in their first three years of graduation or earning less than £25,000).
Day tickets and practice passes are also available.
Super early bird ends on Wednesday 29 May 2024.
www.bevacongress.org
Andy Moores said: "Elbow replacement surgery, despite advancements in both the implant and technique, remains a complex procedure with a demanding rehabilitation process.
"However, for the right candidates, elbow replacement offers the potential for significant improvement in joint function and pain relief, transforming the lives of dogs that would otherwise suffer from permanent discomfort."
The third generation TATE elbow has had a complete redesign to overcome some of the issues associated with the first and second generation models, and the Iowa State system which preceded them.
There are around 15 surgeons qualified to perform the procedure in the world, three in the UK, and Andy is the only one in the South East.
Andy added: "The advancements in the TATE Elbow system represent a significant leap forward in veterinary orthopaedic surgery.
"End-stage elbow osteoarthritis is a horrible condition which can leave dogs in chronic pain and with no good treatment options.
"Being certified to perform third-generation TATE elbow replacements allows us to offer our patients the most advanced treatment options available, giving them the best chance for a pain-free, functional life."
www.mooresortho.com info@mooresortho.com
Thought to be the first agreement of its kind between a buying group and a veterinary practice, Norfolk Farm Vets and agricultural purchasing group Anglia Farmers Limited have come together to offer mutual members and clients a beneficial discount on their monthly vet account when invoiced through Anglia Farmers. Anglia Farmers livestock manager Simon Leach said: "With more than 650 livestock members, Anglia Farmers is keen to give a financial edge wherever possible. Veterinary costs are as much a part of the overall costs we already help with such as feed, equipment and fencing. In terms of dairy, they account for around 0.8p a litre of milk, accumulating to an average of around £1,200 a month for a typical East Anglian dairy of 150 head. Our discount agreement with Norfolk Farm Vets is a very positive step in aiding our members to save even more money through Anglia Farmers."Both parties agree that the time and administration cost saving benefit is equally important.Molly McKay of Norfolk Farm Vets, which has clients throughout the Eastern Counties as well as Lincolnshire, said: "Anyone involved with livestock knows how time-consuming all the paperwork can be. Each month Anglia Farmers collates all the supplier invoices, sends them on to members as part of their monthly statement with a single covering invoice which is so much easier than receiving them piecemeal. And it streamlines administration and cashflow for us as well."
Horiba Medical - UK has launched MLT-Diode Laser Systems, specifically designed for veterinary use, as part of its portfolio of animal healthcare products.
According to the company, the MLT-Diode Lasers are highly versatile and can be used in a variety of veterinary applications including surgery, endoscopy, dentistry and irradiation.
The two models, the MLT-Diode Laser Classic and Premium, both feature touch screen controls and are adaptable to each users individual preferences. Designed with small animal practices in mind, the Classic has a performance out-put of 8 watts whilst the more powerful Premium model is for equine medicine with an output of 15 watts. The system is mounted on a mobile cart with a protection case, allowing the whole system to be moved between treatment rooms and enabling near patient application.
Horiba Medical will be exhibiting the MLT-Diode Laser Systems at the London Vet Show at Olympia, 22nd to 23rd October 2010, on Stand M4.
Intervet/Schering-Plough Animal Health has launched its complimentary blood testing service that allows practitioners to investigate one of the main infectious causes of early embryo loss in sheep flocks.
The annual subsidised Barren EweCheck diagnostic scheme is available from 1st December 2010 until 31st March 2011 for breeding ewe flocks. The service establishes whether Toxoplasma gondii is potentially implicated in any empty or aborting ewes.
According to the company, data from the Barren EweCheck and FlockCheck 2010 schemes showed that 86% of flocks had been exposed to the toxoplasma parasite at some point before blood sampling. As a result, practitioners were able to give clients receiving a positive diagnosis timely advice on disease control and the benefits of a Toxovax vaccination regime.
The company anticipates full availability of Toxovax in 2011 and says its Barren EweCheck blood sample submission pads are available directly from the company's Veterinary Support Group by calling 01908 685685.
Bayer Animal Health has organised for prominent clinical microbiologist Dr Joseph Blondeau, from Canada's University of Saskatchewana, to tour the UK in May, giving talks to practitioners about effective antibiotic usage to prevent bacterial resistance.
Bayer's Technical Veterinary Adviser, Lucy Smith, will also be giving a talk: Maximise Treatment Success, which comes at the subject from the practical veterinary side.
Bayer Animal Health Marketing Manager, Dr Markus Edingloh said: "We are incredibly fortunate to work with such an eminent expert. Dr Blondeau is a leading authority on a new parameter that supports a dosing concept to minimise selection of bacterial resistance - the Mutant Prevention Concentration. Fortunately, he is also expert at presenting complex matters in an engaging and memorable way."
He added: "Lucy Smith will share her specific experience of Bayer's recently launched Veraflox (pradofloxacin), the first and only next generation veterinary fluoroquinolone, which has a broad spectrum of treatment which attacks Gram +, Gram - and anaerobic bacteria, in a highly efficacious way.
The evening events take place on: May 14th (Glasgow), May 15th (Derby), May 16th (Swindon) & May 17th (Surrey). Full details in the VetSurgeon Diary.
Each roadshow session is equivalent to 1.5 hours of free Continuing Professional Development (CPD).
To register to attend one of the roadshows, please email animal.health@bayer.com
Before joining Defra, Christine served as the CVO for New South Wales, Australia, a position she'd held since August 2016. During her tenure there, she led the implementation of new outcome-focused and risk-based biosecurity legislation, online animal certification processes and improved evidence- and risk-based disease control approaches.
Christine comes from a farming family in the south of Scotland, with a background in beef cattle and sheep.
Prior to moving to Australia, she worked for a number of years in private practice in Scotland and the north of England with specific interest in research, meat processing and livestock genetics. She then joined the Animal Health agency (now part of the Animal and Plant Health Agency) in 2008 as a Divisional Veterinary Manager in Scotland. She also led Defra’s Animal Traceability and Public Health policy team, detecting and responding to new and emerging diseases such as Schmallenberg and Porcine Epidemic Diarrhoea.
Christine said: "I am delighted to have been appointed. It is a privilege to take over from Nigel and lead my veterinary colleagues to support our farming and food industry on the UK reputation for high health and welfare of our animals.
"I am very much looking forward to working again with the team at Defra, its agencies, the devolved administrations and all the individuals and groups who will contribute to meet future challenges.
"Our Secretary of State has confirmed he wants to cement the UK’s place as a world-leader on animal health and welfare as the UK leaves the European Union, and I’m delighted to have an opportunity to play a part in that."
Before becoming a dragon, Jenny worked in banking for 30 years and will be sharing her experiences as an entrepreneur and business leader. She became CEO of cash machine company Hanco, bought out the business, turned it around and sold it for £50 million.
Jenny is supportive of the move to host BSAVA Congress online. She said: “Veterinary communities, like other professions, have seen the value that online technologies can offer, both for networking and socials, as well as essential CPD. We should all embrace these changes and look at the value that they can bring.”
The Congress programme is currently being finalised and the organisers say the emphasis is on ensuring the experience is an interactive as possible for each delegate. It will deliver more than 100 hours of CPD, delivered by globally recognised speakers.
BSAVA Congress 2021 Programme Committee Chair Andy Green said: ‘Whether a virtual or a live event our entire programme is proudly created by the profession, for the profession and we are committed to providing unrivalled education, with topical, clinically relevant and evidence-based content.”
There'll be a virtual commercial exhibition, where delegates will be able to chat with exhibitors from the comfort of their home or consult room. There will also be the ability to network with others in the profession, in face-to-face chat rooms. Professor Ian Ramsey, President of the BSAVA said: “BSAVA Congress 2021 is going to be one of the most innovative in the history of our events.
"While the pandemic circumstances we continue to find ourselves in are far from ideal, we must continue to evolve and progress as a profession. BSAVA Congress is a unique highlight in our calendar for next year and it is shaping up to be a truly memorable event."
For further information and to register your interest click here: https://www.bsavaevents.com/bsavacongress2021/en/page/home
The GDP offers one-to-one mentoring, alongside professional and clinical skills development in primary care practices across the UK.
Chloe Roberts, clinical and educational development manager at Linnaeus, said: “This fourth cohort of graduates is looking likely to be the biggest yet, which is testament to how successful the programme has become over recent years.
“We’ve received so many high-quality applications and look forward to welcoming many of them into our practices.
“There’s still time left for people to apply via our online portal, so we’d love to hear from any prospective candidates interested in roles in the Midlands and Yorkshire.”
Linnaeus delivers all clinical training in-house through its extensive network of specialists, referral clinicians, certificate holders and experienced primary care clinicians.
Graduates take part in 20 core educational days as part of their clinical and professional skills training, with access to an additional 10 CPD days to undertake training of their own choice over the course of the programme.
For more information about the Graduate Development Programme, visit https://graduates.linnaeusgroup.co.uk.
Photo: Bristol University graduate Abigail McCarthy, a vet at Blacks Vets in Dudley
CPD Solutions has launched the Webinar Club offering twelve interactive online lectures in key small animal topics each year.
According to the company, the Webinar Club will deliver concise, informative presentations in essential areas for first opinion practice, from specialist tutors in small animal medicine, surgery and imaging. Webinar attendees will have the chance to ask questions in the general discussion at the end of each session.
CPD Certificates will be provided by CPD Solutions for all webinar attendees, and recorded webinars will be available on the Webinar Club website at http://www.veterinarywebinars.com/ for members to watch at any time.
The first webinar on March 22nd is 'How to Manage Diaphragmatic Hernias' by leading soft tissue surgeon Jonathan Bray of Massey University. This is followed by 'Headaches and Pains in the Neck' by Neurology Specialist Simon Platt of the University of Georgia, and 'Decision Making in Oncology' by David Argyle of Edinburgh University.
You can watch a free demonstration webinar by joining Webinar Club as a Silver member at http://www.veterinarywebinars.com/ .
The new policy has been published ahead of an upcoming review of England’s Welfare of Animals at the Time of Killing regulations (WATOK) by the Department for Environment, Food and Rural Affairs (DEFRA).
Recommendations in the policy address all areas of the slaughter process, including:
The policy also covers a wider range of species and focuses on some of those species-specific needs.
For the first time its recommendations include fish. In order to improve the welfare of farmed finfish, BVA says that UK Governments should include the effective stunning of finfish as well as general welfare protections in WATOK regulations. It also calls for more research into developing effective and humane methods of stunning for decapods (shrimp, lobsters and crabs) and cephalopods (squid and octopus) as well as wild caught fish.
BVA Senior Vice President, Simon Doherty said: "With millions of animals slaughtered each year to provide us with the food we eat, we have a responsibility to provide them with a life worth living and a humane death. Our updated position aims to do just that by building on existing legislation and guiding the industry in a direction that better protects the welfare of animals destined for the food chain.
"Slaughter processes should be designed to minimise avoidable pain, distress, fear, and suffering and this document looks at all of the ways that we as vets can work with industry bodies and farm colleagues to improve the legislation already in place.”
A snapshot survey carried out in 2018 by the Food Standards Agency (FSA) for the period of one week revealed that nearly 20 million animals (excluding fish) were slaughtered across 248 operating plants in England and Wales during that time.
In order to effect change for such a high quantity of animals, BVA’s new position sets out recommendations for a range of stakeholders, government, industry, researchers and the veterinary profession, at each stage of the slaughter process. Improvements to the way that stunning data is captured and reported on is also on the list of asks, as well as improving regulation of non-stun slaughter and working collaboratively with Islamic scholars and Halal certification bodies to promote the acceptability of recoverable stunning.
Simon added: "From making sure that stunning methods are as effective as possible, to looking at the specific needs of each species, revalidation of training for operators, and championing the role of the Official Veterinarian, there is a lot of work to be done but we look forward to progressing these recommendations and working to improve the welfare of farmed animals across the UK."
For the study “Comparative accuracy of two veterinary-calibrated point-of-care glucometres for measurement of blood glucose concentration in dogs” blood was sampled from client and staff-owned dogs above 6 months of age, of various breeds and health status.
The samples were then used to compare the accuracy of both PGBMs against a reference method - the hexokinase reaction method.
The authors say this was the first study to investigate AccuTell and the first published evidence comparing AlphaTrak2 with a reference method.
The study also sought to determine how useful the monitors are in clinical decision making and to assess the effect that packed cell volume (PCV) (known to affect the reliability of blood glucose concentration measurement in dogs) has on blood glucose concentration using the two PBGMs.
AccuTell was found to be more accurate and useful in a clinical setting than AlphaTrak2.
Both PBGMs were inaccurate in comparison with the hexokinase reaction method, and although they have potential for standard clinical use, unexpected blood glucose concentrations need to be checked by the hexokinase reaction method.
In addition, measurement of blood glucose concentration by the AlphaTrak2 was affected by PCV whereas measurement by the AccuTell was not.
Nicola Di Girolamo, Editor of JSAP said: “We oftentimes think that an instrument that is developed specifically for our patients will provide satisfactorily results on most occasions.
"Instead, studies such as the one presented here, are critical to understand whether the ‘numbers’ provided by an instrument are reliable for clinical use.
"The authors provided 95% limits of agreements to their results.
"This value is of great help for clinicians, since it shows the difference expected between the instrument and the reference standard in the majority of occasions.”
The study can be read online here: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jsap.13491
Pulborough-based Arun Veterinary Group has been awarded the title of Best UK Vets, having achieved the largest number of positive online reviews on www.vethelpdirect.com.
The awards are based on the number of positive reviews (4 stars and above) left by owners on the site over the course of the year, with owners asked to review the practice on five key areas: respect for my animal, professionalism, friendliness, cleanliness and value for money.
Comments attached to the 182 reviews for Arun included: "Nothing is too much trouble", "Fabulous vets" and "More like good friends."
Vet Help Direct said: "A good online reputation is so valuable to both local people looking for a service and to business owners. That's why online vet reviews are at the heart of our vet directories. Vet Help Direct is determined to provide a fair reflection of the vet practices in their online directories; all reviews are subject to rigorous tests of authenticity, all are checked for duplicate IP addresses, email addresses and some reviewers are asked to provide evidence that they are recent clients of the practice."
In second place was St Georges Veterinary Group, Wolverhampton, which is now up to 132 reviews and in third place was Goddard Veterinary Group, Gidea Park in London, with 122 reviews.
Bayer Animal Health has launched Back to Basics, a new guide to antibiotic use which focuses on the concerns raised by vets and vet students about antibiotics in a survey carried out by the company.
465 vets and 40 students took part in the survey in March 2014. Of these:
27% of vets admitted that they struggle to know which antibiotic is the most appropriate for a specific condition. This uncertainty was particularly the case if the patient is un-responsive to the vet's first choice antibiotic, or the condition develops to require a new or additional antibiotic choice. Bayer says it is also clear that many vets may not be aware that pradofloxacin is the least likely of the veterinary fluoroquinolones to select for antibiotic resistance,2 as 23% of vet students and 9% of vets said they believe that all antibiotics carry the same risk of selecting for resistance.
The company says Back to Basics is designed to fill the gaps in knowledge identified by the survey. It presents each of the major classes of veterinary antibiotic and details how they work. It also includes an antibiotics 'jargon buster' to help vets and vet students better understand the commonly used measures of antibiotic activity and make more informed decisions about the use of antibiotics in practice.
Bayer has also developed an online self-assessment quiz that allows vets and students to check their knowledge. The quiz and the guide are both available at www.veraflox.co.uk
References
The RCVS Trust is offering vets, veterinary nurses and their friends chance to win a stylish small car - and support this small charity - for a mere £2.00.
On offer in this better-than-the-average raffle is a Fiat 500, the 2008 European Car of the Year winner - and described by Jeremy Clarkson as "practical without being boring".
You can buy tickets online at http://www.everyclick.com/rcvstrust until 21 August, or ask Sarah Briggs at the Trust (020 7202 0743 or s.briggs@rcvstrust.org.uk) for a book to sell to colleagues, friends and family.
Tickets will then be entered into the Small Charity Car Draw, organised by the Foundation for Social Improvement, with the Trust receiving over 95% of the ticket price. The draw will take place on 1 October 2009.
A research project funded by The Horse Trust has discovered that a racehorse's performance does not markedly change after it has recovered from a tendon injury.
The research was led by Bryan O'Meara, who is in the final year of a three year clinical training scholarship funded by The Horse Trust.
Mr. O'Meara carried out the research at Donnington Grove Veterinary Surgery in Newbury, under the supervision of epidemiologist Dr Tim Parkin from University of Glasgow.
Tendonitis is one of the most common musculoskeletal injuries in racehorses, with a prevalence of 11-30%, according to earlier research.
Mr. O'Meara examined the clinical records and racing histories of 400 racehorses who had been treated for superficial digital flexor (SDF) tendonitis injuries over a five year period (2003-2008).
The race records of horses affected by tendon injury were compared with 400 matched control horses that had never suffered SDF tendon injuries.
The controls were horses training in the same establishment at the time of injury and of the same age and sex as the case horse.
The research looked at the performance of the racehorses in races before and after treatment for the injury, and at the performance of the control horses before and after the treatment date. The Racing Post Rating (RPR), which is published by the Racing Post after every race, was used as a measure of performance.
Mr. O'Meara found that there was no significant difference in RPR before and after the treatment date in case and control horses.
According to The Horse Trust, this result is unexpected as in vitro studies have found that healed tendon tissue has reduced elasticity due to the presence of scar tissue. This suggests that a horse with a healed SDF tendon would need to work its muscles harder to compensate and would therefore be expected to have lower performance.
Mr. O'Meara said more research is needed to back-up his finding that performance isn't significantly affected by tendon injury: "It could be that using Racing Post Rating to measure performance isn't sensitive enough to pick up a change in the horse's performance. However, it's encouraging that there's no marked change in performance after a horse has recovered from a tendon injury. These findings show that there's no need to give up on a horse that has a tendon injury - they can still come back and perform well, or can be used for other, less demanding riding activities."
The research also found that there was no significant difference between case and control horses when returning to racing and completing three races. Only after completing five races, or three years post treatment, was a significant difference found between case and control horses. This finding is a step towards developing a more accurate assessment of tendon treatment. Outcome after five races or three years post treatment is a better indicator of the outcome of treatment.
Mr. O'Meara said: "At the moment, some tendon treatments state their success as the percentage of horses that return to racing after treatment. However, we've shown that there's no significant difference between case and control horses at this time. At the moment, there are a myriad of treatments available to treat tendonitis. Hopefully this finding will be used in further research to learn which treatments are most effective."
Mr O'Meara's research also found a link between SDF tendon injury and the racehorse competing at its maximum performance level: the case horses were significantly nearer to their pre-injury maximum performance level in the race immediately before injury (compared to matched controls), suggesting that they were competing nearer their individual maximum performance level when the SDF tendon injury occured.
Virbac has announced the launch of what it describes as an affordable ciclosporin for the treatment of canine atopic dermatitis.
Called Cyclavance, the new product will make its debut at the London Vet Show (Nov 20th/21st at London Olympia).
Cyclavance is presented in a liquid formulation for precise dosing, in a container with a new 'AdaptaCap' designed to ensure leak proof dispensing and give the product a 6 month shelf life after being broached. Cyclavance is offered in four size presentations - 5 ml, 15 ml, 30 ml and 50 ml - to give practices maximum flexibility in its use.
Sarah Walker MRCVS, Product Manager, said: "Atopic dogs present at practices across the country on a daily basis. It is a challenging condition which can be hard to treat successfully because owner compliance is so important. By offering Cyclavance at a great price to give greater appeal, allowing a wider scope of use, and with innovative features, such as the unique AdaptaCap, we aim to help practices achieve better outcomes for their patients and increase the number of clients it is available to.
The new course is called ‘New staff training course with Post2Pet’, and, as the name suggests, it will look at how to incorporate the home delivery option into a preventative healthcare plan.
Premier Vet Alliance says the course is suitable for any member of the practice team that wants to increase their knowledge about healthcare plans.
The course is 4 modules long with an assessment leading to 1.5 hours of completed CPD. It will launch towards the end of April.
James Tudor, Head of Customer Experience at Premier Vet Alliance, said: "This is a fantastic resource and I am I so proud of the team who’ve developed this and helped practices to train staff efficiently and effectively.
"It’s opening up the future of training and we hope to gain guidance in developing our training provision by working directly with practices, to help keep the training relevant.
"We see real value in CPD accredited courses, especially where they help enable veterinary staff to increase their knowledge on maximising their clients’ compliance. They can also learn how to influence animal health, and drive other aspects of the business through health plans."
"This is just the beginning; we will continue to increase our CPD accreditations and share best practice across Europe and the United States."
For more information contact 0117 370 0300 or email pcp@premiervetalliance.co.uk .
Vetoquinol UK has launched Marbocyl Solo – a one shot treatment for Bovine Respiratory Disease. Marbocyl Solo is a 100mg/ml solution of marbofloxacin given as one injection IM at 8mg/kg. It treats sick animals fast, killing bacteria in one go, therefore minimising lung damage and consequential morbidity. This fast action reduces the risk of the spread of infection. On top of that, Marbocyl Solo has a meat withdrawal of only 3 days (milk 3 days). “Marbocyl is a well proven antibacterial that is extensively used in cattle practice,” explains Alvin Cerely, Marbocyl’s product manager. “Marbocyl Solo is exceptionally well placed for applying ‘concentration killing’ or a‘strike action’ strategy as opposed to a ‘long action’ strategy used by other antibiotics. Marbocyl Solo is available as a separate presentation to Marbocyl 10% to avoid confusion, particularly with farmers, on different dosage regimes and withdrawal periods.”
Marbocyl Solo is available now and details have been mailed to all cattle vets in the UK and Ireland. Please contact your Vetoquinol representative or telephone 0800 169 8197 for more details.
Animalcare has announced the launch of a new epilepsy monitoring programme to support users of its Phenoleptil (phenobarbital) tablets.
As part of the programme, veterinary surgeons can have patients' phenobarbital plasma levels analysed by Carmichael Torrance Diagnostic Service (CTDS). CTDS Veterinary Director Nick Carmichael (RCVS Recognised Specialist in Veterinary Clinical Pathology) and his team will also be available both to interpret results and discuss all aspects of therapeutic monitoring at no extra cost.
In addition, veterinary surgeons can opt for additional chemistry, including bile acids to assess hepatic function plus haematology. All Phenoleptil users are eligible for 50% discount off these services.
Animalcare has also expanded the Phenoleptil range and launched new strength tablets of 25mg and 100mg. Presented as new "snap- tabs" with a four-way score for more accurate dosing, whatever the weight of the dog, this enables fine adjustments to be made thereafter, reducing the risk of sub-optimal dosing.
The 100 tablet packs are designed for quick and easy dispensing with flavoured tablets to aid compliance. The 12.5mg and 25mg strengths are the only phenobarbital tablets licensed for dogs under 12kg and make it possible to treat dogs as low as 2.5kg (assuming a 2.5mg/kg bid starting dose) in weight. The 100mg tablets are useful to treat larger dogs.
For more information, contact your local Animalcare representative.